Copyright © Fidelis Security. All rights reserved.
-
Privacy PolicyPrivacy Policy
-
Terms of ServiceTerms of Service
-
Trust CenterTrust Center
-
SecuritySecurity
Fidelis Security brings to you a wealth of information with our webinars delivered by cybersecurity experts!
Lyell Immunopharma is a South San Francisco-based, publicly traded cell therapy company (LYEL). Their T cell reprogramming technology focuses on the mastery of T cells to cure patients with solid tumors. They apply proprietary genetic and epigenetic reprogramming technology platforms to address barriers present in solid tumors in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.
Join Fidelis Security's experts as they decode how to overcome...
Read WebinarJoin our newsletter to stay up to date on features and releases.